<DOC>
	<DOC>NCT00171275</DOC>
	<brief_summary>This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.</brief_summary>
	<brief_title>Fluvastatin in the Therapy of Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Acute coronary syndrome Adults, 18 years and older History of lipid lowering therapy less than 30 days before index event Pregnancy and nursing Subject younger than 18 years Other inclusion and exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Coronary disease</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Statins</keyword>
</DOC>